Streetbeat News

Stock Prices

NVAX

Novavax (NASDAQ:NVAX) is scheduled to release its quarterly earnings report on February 28, 2024, with analysts expecting an EPS of $-0.50. Despite past earnings beats, Novavax's stock price has experienced declines following earnings announcements. Shares are currently trading at $5.5, down 16.18% over the last year. Investors are looking for positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 6:01 pm

BONKUSD

DOGEUSD

PEPEUSD

SHIBUSD

Dogecoin (DOGE) experienced a 10% rally, driven by a significant increase in large transactions and recent ecosystem developments. Trading volumes surged 319.6%, and DOGE re-entered the top 10 cryptocurrencies by market cap. Twitch announced it would accept DOGE for its Turbo subscription, and Bitflyer, a major Japanese exchange, listed DOGE. Whale transactions and derivatives metrics also saw increases. Dogecoin led meme coins in social activity, outperforming Shiba Inu (SHIB), Pepe (PEPE), and Bonk (BONK). Analysts and traders are bullish, with predictions of further price increases.

Portfolio Pulse from Khyathi Dalal

February 27, 2024 | 6:01 pm

VYGR

Voyager Therapeutics (NASDAQ:VYGR) is scheduled to release its quarterly earnings report on February 28, 2024, with an estimated EPS of $-0.29. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Historical data shows mixed reactions to past earnings, with the stock price fluctuating based on the actual EPS compared to estimates. Shares have risen 22.39% over the last 52 weeks, indicating a generally positive outlook from long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 6:01 pm

MIRM

Mirum Pharmaceuticals (NASDAQ:MIRM) is scheduled to release its quarterly earnings report on February 28, 2024. Analysts predict an EPS of $-0.24. The company's past performance shows a mixed reaction to earnings reports, with the stock price fluctuating based on actual EPS versus estimates and guidance provided. Shares are currently trading at $29.06, reflecting a 22.91% increase over the last 52 weeks. Investors are optimistic but will be closely watching the guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 6:01 pm

KNSA

Kiniksa Pharmaceuticals (NASDAQ:KNSA) is scheduled to release its quarterly earnings report on February 28, 2024. Analysts predict an EPS of $-0.14. The company's past earnings performance shows a mix of misses and beats, with the stock price reacting accordingly. Shares are currently trading at $20.16, up 65.71% over the last 52 weeks. Investors are looking for not just an earnings beat but also positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 6:00 pm

BBSI

Barrett Bus Servs (NASDAQ:BBSI) is scheduled to release its quarterly earnings report on February 28, 2024, with an estimated EPS of $1.90. Historical data shows the company has previously beaten EPS estimates, leading to positive stock price movements. Shares are currently trading at $115.83, reflecting a 20% increase over the last 52 weeks. Investors are looking forward to not only the earnings results but also the company's future guidance.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 6:00 pm

FCX

Financial analysts have observed a bullish trend in the options market for Freeport-McMoRan (NYSE:FCX), with 55% of traders showing bullish sentiment. The analysis highlighted 9 unusual trades, with a preference for calls over puts, indicating an expectation for FCX's stock price to reach between $30.0 and $42.0 in the next three months. The company, a major international mining entity, has seen its stock price increase by 1.66%, with a current price of $38.66. The next earnings report is expected in 52 days.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 6:00 pm

CVX

Financial analysis of Chevron's (NYSE:CVX) options market reveals a bearish sentiment among traders, with 57% showing bearish tendencies. The analysis predicts a price range of $130.0 to $170.0 for Chevron, based on unusual trade activity and options volume and interest. Noteworthy options activity includes both bearish and bullish trades with expiration dates ranging from April 2024 to July 2024. Chevron, a major integrated energy company, has seen its stock price decrease by -0.6%, with a current price of $153.53. Industry analysts have set an average target price of $175.0, with opinions varying from Outperform to Hold.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 6:00 pm

EBAY

EL

ULTA

ZM

The CNBC Halftime Report featured final trade recommendations, highlighting Zoom Video Communications (ZM), eBay (EBAY), Estee Lauder (EL), and Ulta Beauty (ULTA). These companies were selected based on their current market performance and potential for future growth.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 6:00 pm

MHO

M/I Homes (NYSE:MHO) has significantly outperformed the market with an annualized return of 23.66% over the past 5 years, resulting in an average annual return of 36.24%. A $100 investment in MHO 5 years ago would now be worth $473.43. The company's current market capitalization stands at $3.40 billion.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 6:00 pm